Home > Resources > Whitepapers > The real cost of patient misidentification

The real cost of patient misidentification

August 1, 2018

Undeniably, the most serious threat of misidentification is patent safety, but the possible financial consequences must also be calculated. In fact, when the University of Utah Health examined how much just one facet of patient misidentification – duplicate medical records – could cost; the results were staggering: $650,000 for a master patient index cleanup, $15,000 per year attributable insurance write-offs, $60-100 or higher per incident to clean up overlays

Spotlight

Westmeria Healthcare LTD

Since it was founded in 1999 and through merging with the Apex Group, Westmeria Healthcare has become a market leading developer, manufacturer and supplier of pressure area care equipment, medical beds, and manual handling equipment, with an emphasis on serving the healthcare needs of patients throughout the UK. A comprehensive support system has been designed to reduce the on-going cost of care by both prolonging the life expectancy of equipment and reducing the risk posed to patients; including decontamination, maintenance and repair, competency based training, audits and LOLER testing.

OTHER WHITEPAPERS

A vision for Medical Affairs in 2025

whitePaper | March 11, 2023

As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities.

The Rise of Hybrid Clinical Trials

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

The Cost of Not Having Healthcare CRM

whitePaper | November 20, 2019

This whitepaper examines the financial implications of an effective CRM system, without which your organization risks. To acquire and retain patients, health systems have to connect with their customers cost-effectively. And along the way, they need to detect and measure to what extent their marketing efforts are making an impact.

Planning your first-in-human trial

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

Artificial Intelligence Helps Clinicians Tell the Complete Patient Story

whitePaper | January 27, 2022

Missing secondary diagnoses can negatively impact patient outcomes and lead to costly readmissions. However, requiring staff to read over every patient’s chart for any additional diagnoses can contribute to burnout. Workflow-integrated, artificial intelligence (AI)-driven computer-assisted physician documentation (CAPD) systems help clinicians document and code all secondary diagnoses while still focusing on the primary clinical problem, enhancing documentation integrity and reducing readmissions and costs.Read how AI-driven CAPD solutions have helped healthcare organizations

More Whitepapers

The real cost of patient misidentification